Literature DB >> 19692705

Reduced immunoglobulin class switch recombination in the absence of Artemis.

Paola Rivera-Munoz1, Pauline Soulas-Sprauel, Gwenaël Le Guyader, Vincent Abramowski, Sylvia Bruneau, Alain Fischer, Frédéric Pâques, Jean-Pierre de Villartay.   

Abstract

Nonhomologous end-joining DNA repair factors, including Artemis, are all required for the repair of DNA double-strand breaks, which occur during the assembly of the variable antigen recognition domain of B-cell receptors and T-cell receptors through the V(D)J recombination. Mature B cells further shape their immunoglobulin repertoire on antigen recognition notably through the class switch recombination (CSR) process. To analyze the role of Artemis during CSR, we developed a mature B-cell-specific Artemis conditional knockout mouse to bypass the absence of B cells caused by its early deficit. Although CSR is not overwhelmingly affected in these mice, class switching to certain isotypes is clearly reduced both in vitro on B-cell activation and in vivo after keyhole limpet hemocyanin immunization. The reduced CSR in Artemis-deficient B cells is accompanied by the increase in DNA microhomology usage at CSR junctions, the imprint of an alternative DNA end-joining pathway. Likewise, significant increase in DNA microhomology usage is the signature of CSR junctions obtained from human RS-SCID patients harboring hypomorphic Artemis mutations. Altogether, this indicates that Artemis participates in the repair of a subset of DNA breaks generated during CSR.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19692705     DOI: 10.1182/blood-2008-11-188383

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

Review 1.  Immunoglobulin class-switch DNA recombination: induction, targeting and beyond.

Authors:  Zhenming Xu; Hong Zan; Egest J Pone; Thach Mai; Paolo Casali
Journal:  Nat Rev Immunol       Date:  2012-06-25       Impact factor: 53.106

2.  Retinoic acid enhances lactoferrin-induced IgA responses by increasing betaglycan expression.

Authors:  Jeong-Min Lee; Young-Saeng Jang; Bo-Ra Jin; Sun-Jin Kim; Hyeon-Jin Kim; Bo-Eun Kwon; Hyun-Jeong Ko; Sung-Il Yoon; Geun-Shik Lee; Woan-Sub Kim; Goo-Young Seo; Pyeung-Hyeun Kim
Journal:  Cell Mol Immunol       Date:  2015-08-17       Impact factor: 11.530

Review 3.  Recent advances in the study of immunodeficiency and DNA damage response.

Authors:  Tomohiro Morio
Journal:  Int J Hematol       Date:  2017-05-26       Impact factor: 2.490

4.  DCLRE1C (ARTEMIS) mutations causing phenotypes ranging from atypical severe combined immunodeficiency to mere antibody deficiency.

Authors:  Timo Volk; Ulrich Pannicke; Ismail Reisli; Alla Bulashevska; Julia Ritter; Andrea Björkman; Alejandro A Schäffer; Manfred Fliegauf; Esra H Sayar; Ulrich Salzer; Paul Fisch; Dietmar Pfeifer; Michela Di Virgilio; Hongzhi Cao; Fang Yang; Karin Zimmermann; Sevgi Keles; Zafer Caliskaner; S Ükrü Güner; Detlev Schindler; Lennart Hammarström; Marta Rizzi; Michael Hummel; Qiang Pan-Hammarström; Klaus Schwarz; Bodo Grimbacher
Journal:  Hum Mol Genet       Date:  2015-10-16       Impact factor: 6.150

Review 5.  The recent advances in non-homologous end-joining through the lens of lymphocyte development.

Authors:  Xiaobin S Wang; Brian J Lee; Shan Zha
Journal:  DNA Repair (Amst)       Date:  2020-06-25

6.  Lymphopoiesis in transgenic mice over-expressing Artemis.

Authors:  P Rivera-Munoz; V Abramowski; S Jacquot; P André; S Charrier; K Lipson-Ruffert; A Fischer; A Galy; M Cavazzana; J-P de Villartay
Journal:  Gene Ther       Date:  2015-10-01       Impact factor: 5.250

7.  Cernunnos influences human immunoglobulin class switch recombination and may be associated with B cell lymphomagenesis.

Authors:  Likun Du; Roujun Peng; Andrea Björkman; Noel Filipe de Miranda; Cornelia Rosner; Ashwin Kotnis; Mattias Berglund; Chonghai Liu; Richard Rosenquist; Gunilla Enblad; Christer Sundström; Mohammad Hojjat-Farsangi; Hodjattallah Rabbani; Manuel R Teixeira; Patrick Revy; Anne Durandy; Yixin Zeng; Andrew R Gennery; Jean-Pierre de Villartay; Qiang Pan-Hammarström
Journal:  J Exp Med       Date:  2012-02-06       Impact factor: 14.307

8.  Biosafety Studies of a Clinically Applicable Lentiviral Vector for the Gene Therapy of Artemis-SCID.

Authors:  Sabine Charrier; Chantal Lagresle-Peyrou; Valentina Poletti; Michael Rothe; Grégory Cédrone; Bernard Gjata; Fulvio Mavilio; Alain Fischer; Axel Schambach; Jean-Pierre de Villartay; Marina Cavazzana; Salima Hacein-Bey-Abina; Anne Galy
Journal:  Mol Ther Methods Clin Dev       Date:  2019-09-13       Impact factor: 6.698

9.  Novel spontaneous deletion of artemis exons 10 and 11 in mice leads to T- and B-cell deficiency.

Authors:  Christian Barthels; Jacek Puchałka; Tomas Racek; Christoph Klein; Thomas Brocker
Journal:  PLoS One       Date:  2013-09-17       Impact factor: 3.240

Review 10.  Higher Incidence of B Cell Malignancies in Primary Immunodeficiencies: A Combination of Intrinsic Genomic Instability and Exocytosis Defects at the Immunological Synapse.

Authors:  Jérôme Mastio; Mezida B Saeed; Hannah Wurzer; Max Krecke; Lisa S Westerberg; Clément Thomas
Journal:  Front Immunol       Date:  2020-11-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.